The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: Results from the Flint Men's Health Study

Journal of Human Genetics

Volumn 53, Issue 3, 2008, Pages 220-226

  Lange, Ethan M ^a,c   Sarma, Aruna V ^d   Ray, Anna ^e   Wang, Yunfei ^a   Ho, Lindsey A ^b   Anderson, Sarah A ^f   Cunningham, Julie M ^f   Cooney, Kathleen A ^e,g  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Androgen receptor; Association; CAG repeat; GGN repeat; Prostate cancer

Indexed keywords

ADENINE; ANDROGEN RECEPTOR; CYTOSINE; GUANINE;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER INCIDENCE; CANCER MORTALITY; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RECEPTOR GENE; TANDEM REPEAT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS; UNITED STATES;

EID: 40049108720     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-007-0240-4     Document Type: Article

References (36)

1. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Balter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38:652-658
2. Beilin J, Ball EM, Favaloro JM, Zajac JD (2000) Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25:85-96
3. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho S, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters DJ, Timms B (2004) Human prostate cancer risk factors. Cancer 101:2371-2490
4. Brawn PN, Johnson EH, Kuhl DL, Riggs MW, Speights VO, Johnson CF 3rd, Pandya PP, Lind ML Bell NF (1993) Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer 71:2569-2573
5. Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186
6. Chang BL, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Carpten JD, Bleeker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB, Xu J (2002) Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Hum Genet 110:122-129
7. Cooney KA, Strawderman MS, Wojno KJ, Derr KM, Taylor A, Alscer KH, Heeringa SG, Taylor JM, Wei JT, Montie JE, Schottendfeld D (2001) Age-specific distribution of serum prostate-specific antigen in a community-based study of African American men. Urology 57:91-96
8. n CAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 7:357-362
9. Ding D, Xu L, Menon M, Reddy GP, Barrack ER (2004) Effect of short CAG (glutamine) repeat on human androgen receptor function. Prostate 58:23-32
10. Ding D, Xu L, Menon M, Reddy GP, Barrack ER (2005) Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen function. Prostate 62:133-139
11. Esteban E, Rodon N, Via M, Gonzalez-Perez E, Santamaria J, Dugoujon JM, Chennawi FE, Melhaoui M, Cherkaoui M, Vona G, Harich N, Moral P (2006) Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships. J Hum Genet 51:129-136
12. Fowler JE Jr, Bigler SA (1999) A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate cancer. Cancer 86:836-841
13. Fowler JE Jr, Bigler SA, Bowman G, Kilambi NK (2000) Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment. J Urol 163:150-151
14. Freedman ML, Pearce CL, Penney KL, Hirschhorn JN, Kolonel LN, Henderson BE, Altshuler D (2005) Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study. Am J Hum Genet 76:82-90
15. Gaston KE, Kim D, Singh S, Ford OH, Mohler JL (2003) Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol 170:990-993
16. Gilligan T, Manola J, Sartor O, Weinrich SP, Moul JW, Kantoff PW (2004) Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population. Clin Prostate Cancer 3:98-103
17. Hedrick PW (1987) Gametic disequilibrium measures: proceed with caution. Genetics 117:331-341
18. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C (2000) Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 60:5111-5116
19. Irvine RA, Yu MC, Ross RK, Coetzee GA (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55:1937-1940
20. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer Statistics, 2007. CA Cancer J Clin 57(1):43-66
21. n -expanded neuronopathies. 4:523-527
22. Kittles RA, Young D, Weinrich S, Hudson J, Argyropoulos G, Ukoli F, Adams-Campbell L, Dunston GM (2001) Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk. Hum Genet 109:253-261
23. Lewontin RC (1964) The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49:49-67
24. Moul JW, Connelly RR, Mooneyhan RM, Zhang W, Sesterhenn IA, Mostofi FK, McLeod DG (1999) Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol 162:394-397
25. Olapade-Olaopa EO, Muronda CA, MacKay EH, Danso AP, Sandhu DP, Terry TR, Habib FK (2004) Androgen receptor protein expression in prostatic tissues in Black and Caucasian men. Prostate 59:460-468
26. Panz VR, Joffe BI, Spitz I, Lindenberg T, Farkas A, Haffejee M (2001) Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men. Endocrine 15:213-216
27. Powell IJ, Banerjee M, Sakr W, Grignon D, Wood DP Jr, Novallo M, Pontes E (1999) Should African-American men be tested for prostate carcinoma at an earlier age than white men? Cancer 85:472-477
28. Pritchard JK (2000) Association mapping in structured populations. Am J Hum Genet 67:170-181
29. Rajender S, Singh L, Thangaraj K (2007) Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl 9:147-179
30. Roberts RO, Bergstralh EJ, Cunningham JM, Hebbring SJ, Thibodeau SN, Lieber MM, Jacobsen SJ (2004) Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am J Epidemiol 159:269-276
31. Salinas CA, Austin MA, Ostrander EO, Stanford JL (2005) Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. Prostate 65:58-65
32. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Badzioch M, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Guy M, Hsieh C-L, Halpern J, Balise RR, Oakley-Girvan I, Whittemore AS, Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Friedrichsen DM, Deutsch K, Kolb S, Janer M, Hood L, Ostrander EA, Stanford JL, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Lange EM, Ho LA, Beebe-Dimmer JL, Wood DP, Cooney KA, Seminara D, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLJ, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Catalona WJ, Suarez BK, Roehl KA (2006) Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 120:471-485
33. Thompson I, Tangen C, Tolcher A, Crawford E, Eisenberger M, Moinour C (2001) Association of African-American ethnic background with survival in men with metastatic prostate cancer. J Natl Cancer Inst 93:219-225
34. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82:3777-3782
35. Vijayakumar S, Winter K, Sause W, Gallagher MJ, Michalski J, Roach M, Porter A, Bondy M (1998) Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12. Int J Radiat Oncol Biol Phys 40:17-25
36. Zeegers MP, Kiemeney LALM, Nieder AM, Ostrer H (2004) How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 13:1765-1771